New research reveals konjac glucomannan’s frozen gel form significantly boosts SCFA production and gut microbiota diversity in obese mice, offering promising implications for human diabetes mana...
Recent research reveals how specific probiotic strains improve mental health, digestion, and immune response, with updated guidelines on synbiotics for metabolic health. Emerging studies confirm probi...
New research reveals konjac glucomannan sol (KS) significantly improves glucose control and gut health, offering a promising dietary intervention for metabolic disorders. Cutting-edge studies demonstr...
New research reveals konjac glucomannan’s metabolic effects vary dramatically between sol and gel states, offering insights for personalized nutrition in obesity management. Cutting-edge studies...
New research reveals how konjac glucomannan’s physical state (gel vs sol) differentially modulates gut microbiota and metabolic outcomes, with frozen gels showing surprising stability. Cutting-e...
Exploring how gut microbiome influences weight, the role of probiotics, prebiotics, and emerging treatments like fecal microbiota transplantation for obesity. Recent studies reveal how gut bacteria im...
Emerging research shows prenatal PFAS exposure significantly increases risks of diabetes and obesity later in life, with new mechanisms of endocrine disruption identified. Groundbreaking studies demon...
New research reveals konjac glucomannan’s multifaceted effects on gut microbiota, appetite regulation, and lipid metabolism, offering promising strategies for obesity management. Emerging clinic...
New research demonstrates queen bee larvae freeze-dried powder’s ability to combat obesity by reshaping gut microbiota and improving liver metabolism in mouse studies. Emerging research reveals ...
Recent research demonstrates how konjac glucomannan’s physical state (sol, gel, frozen gel) differentially affects glucose metabolism, lipid profiles, and gut microbiota in obese mice. Groundbre...
